001     283106
005     20260217130024.0
024 7 _ |2 doi
|a 10.1186/s12889-025-25531-w
024 7 _ |2 pmid
|a pmid:41469611
024 7 _ |2 pmc
|a pmc:PMC12755007
037 _ _ |a DZNE-2026-00002
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Callaway, Julia
|b 0
245 _ _ |a Ageing populations: new challenges in longevity.
260 _ _ |a London
|b BioMed Central
|c 2025
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1767343258_32511
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a High-income countries experienced unprecedented gains in life expectancy throughout the twentieth century. However, recent evidence suggests that these gains have slowed, especially at older ages. This paper focuses on recent trends in life expectancy and health in ageing populations in high-income countries.We analysed mortality and health data from the Human Mortality Database and the Global Burden of Disease. Additionally, we reviewed recent literature to explore changes in life expectancy, health-adjusted life expectancy, physical and cognitive decline, and the impact of ageing on healthcare expenditure in countries with high life expectancies.Although life expectancy continues to rise in high-income countries, the pace of improvement has slowed, especially among the oldest-old. While health-adjusted life expectancy has generally increased, the proportion of life spent in good health varies across countries, with notable differences in trends in physical and cognitive disabilities. In terms of economic implications, these findings highlight the importance of age and proximity to death as determinants of healthcare expenditures.The deceleration in life expectancy gains, particularly among the oldest populations, raises important questions about future trends in longevity. As physical and cognitive health change in older ages healthcare systems will face new and diverse challenges. Understanding the role of ageing and time-to-death in shaping healthcare costs will be critical for anticipating future needs in high-income countries.
536 _ _ |0 G:(DE-HGF)POF4-354
|a 354 - Disease Prevention and Healthy Aging (POF4-354)
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |2 Other
|a Cognitive health
650 _ 7 |2 Other
|a Health economics
650 _ 7 |2 Other
|a Health expectancies
650 _ 7 |2 Other
|a Mortality
650 _ 7 |2 Other
|a Physical health
650 _ 2 |2 MeSH
|a Humans
650 _ 2 |2 MeSH
|a Life Expectancy: trends
650 _ 2 |2 MeSH
|a Aged
650 _ 2 |2 MeSH
|a Longevity
650 _ 2 |2 MeSH
|a Aged, 80 and over
650 _ 2 |2 MeSH
|a Aging
650 _ 2 |2 MeSH
|a Male
650 _ 2 |2 MeSH
|a Developed Countries: statistics & numerical data
650 _ 2 |2 MeSH
|a Female
650 _ 2 |2 MeSH
|a Health Expenditures: trends
650 _ 2 |2 MeSH
|a Middle Aged
650 _ 2 |2 MeSH
|a Mortality: trends
650 _ 2 |2 MeSH
|a Global Burden of Disease
650 _ 2 |2 MeSH
|a Global Health
700 1 _ |a Strozza, Cosmo
|b 1
700 1 _ |a Christensen, Kaare
|b 2
700 1 _ |0 P:(DE-2719)2811246
|a Doblhammer, Gabriele
|b 3
|u dzne
700 1 _ |a Rau, Roland
|b 4
700 1 _ |a Søgaard, Jes
|b 5
773 _ _ |0 PERI:(DE-600)2041338-5
|a 10.1186/s12889-025-25531-w
|g Vol. 25, no. 1, p. 4395
|n 1
|p 4395
|t BMC public health
|v 25
|x 1471-2458
|y 2025
856 4 _ |u https://pub.dzne.de/record/283106/files/DZNE-2026-00002.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/283106/files/DZNE-2026-00002.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:283106
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-588)1065079516
|6 P:(DE-2719)2811246
|a Deutsches Zentrum für Neurodegenerative Erkrankungen
|b 3
|k DZNE
913 1 _ |0 G:(DE-HGF)POF4-354
|1 G:(DE-HGF)POF4-350
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|v Disease Prevention and Healthy Aging
|x 0
914 1 _ |y 2025
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
|a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b BMC PUBLIC HEALTH : 2022
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2024-04-10T15:34:53Z
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2024-04-10T15:34:53Z
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2025-01-07
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1012002
|k AG Doblhammer
|l Demographic Studies
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1012002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21